Cell Manufacturing– tag –
-
New Technology
AI/ML and Digital Twins Spearhead Bioprocess Digitalization for Microbial Lipid Production and Downstream Design
ApplyKite Europe Overview The Norwegian University of Life Sciences (NMBU) and University College Dublin (UCD) have launched PhD scholarship programs focused on AI/ML frameworks for bioprocess digitalization. NMBU's "fermentAtIon" projec... -
New Technology
Exreprotein Launches Animal-Derived Component-Free Cell Culture Supplement for Immune and Stem Cell Research, Enhancing Consistency and Performance
Product information/Industry review Unknown Overview Exreprotein has introduced the 'Exreprotein Cell Culture Supplemental Mix,' an advanced formulation specifically designed for immune and stem cell research. This supplement is chemical... -
New Technology
Six Modeling Approaches, Including Digital Twins, Unlock Complex Bioprocess Data for Optimized Manufacturing
BioProcess Online USA Overview Six key modeling approaches, with a strong emphasis on digital twins, are presented for effectively leveraging complex bioprocess data. Digital twins provide a comprehensive virtual representation of physic... -
Cell Culture Technology
Northway Biotech Opens Landmark €61M CDMO in Lithuania, Set to Drive European Cell and Personalized Medicine Manufacturing Scale-Up
chemanager-online.com Lithuania Overview Northway Biotech has launched a state-of-the-art €61 million Contract Development and Manufacturing Organization (CDMO) in Vilnius, Lithuania, specifically designed for cell therapy and personaliz... -
Cell Culture Technology
Serum-Free Media Drives Cell Culture Standardization, Ensuring Reproducibility and Safety Through Defined Composition and Reduced Batch Variability
Procell Germany Overview Comparing serum-containing and serum-free media in cell culture, the article highlights that serum-free media offer clearly defined compositions, minimal batch-to-batch variability, and improved experimental repr... -
Market Trends
Evolving Economics of Single-Use Biomanufacturing: Large-Scale Bioreactors and Process Intensification Expand Commercial Production Strategies
Pharma's Almanac USA Overview The economics of single-use biomanufacturing are increasingly dependent not just on bioreactor volume but on utilization, process productivity, and annual throughput. Specifically, the introduction of larger... -
New Technology
Drug Discovery News Highlights Rising Complexity in Biologics Manufacturing: Urges Manufacturability by Design, Raw Material Quality, and Process Intensification
Drug Discovery News USA Overview Drug Discovery News reports on the increasing complexity in manufacturing biologics, cell-based therapies (including CAR T), viral vectors, and oligonucleotides. The article identifies key challenges such... -
New Technology
BubbleGen: Bracco Imaging’s Bead-Free Microbubble Technology Revolutionizes CAR-T Cell Selection
Manufacturing Chemist Italy Overview Bracco Imaging has launched its BubbleGen CD3+ T Cell Selection Kit, a pioneering bead-free technology set to transform CAR-T cell manufacturing. Leveraging gas-core, lipid-shell microbubbles for gent... -
Cell Culture Technology
CAR-T Cell Therapy Manufacturing Breakthrough: Automated Bioreactors Cut Production Time Below 48 Hours, Reduce Costs by 35%
PMC USA Overview Recent research highlights significant advances in CAR-T cell therapy manufacturing, with automated bioreactors enabling point-of-care biomanufacturing that reduces cell product time to less than 48 hours and cuts costs ... -
Market Trends
Viral Vector Packaging Services Market Signals Rapid Growth Driven by Gene Therapy Commercialization and Increased Biomanufacturing Investment
openPR.com USA Overview This article provides an overview of a market research report from openPR.com. The global viral vector packaging services market is experiencing rapid growth, driven by advancing gene therapy commercialization and...